ReviewFrontiers in microbiology2026
Conjugation as an evolutionary bottleneck in antimicrobial resistance spread.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is commonly framed as a consequence of mutation and selection, yet this perspective does not fully explain the speed and scale of global resistance dissemination. Here, we argue that AMR is better understood as an amplification problem, in which horizontal gene transfer particularly conjugation governs the spread of resistance genes across bacterial populations and ecological compartments. Conjugative plasmids couple high transfer efficiency with broad host range, enabling rapid dissemination of resistance determinants, including those conferring resistance to last-resort antibiotics. This review synthesizes evidence showing that conjugation is shaped by tightly constrained trade-offs between transfer efficiency, fitness cost, plasmid copy number, and ecological context. These constraints render conjugation a rate-limiting step in dissemination dynamics, such that even modest reductions in transfer efficiency can substantially reduce plasmid persistence and spread. At the same time, plasmids exhibit adaptive features, including compensatory evolution and dynamic regulation of replication, that stabilize their persistence and complicate intervention. This duality positions conjugation as both a central driver of AMR and a tractable therapeutic target. We review emerging strategies to disrupt conjugation, including small-molecule inhibitors, CRISPR-based systems, phage approaches, and ecological interventions, and highlight key challenges related to delivery, evolutionary escape, and real-world implementation. We propose that targeting gene flow rather than gene emergence alone offers a complementary strategy for controlling AMR. By reframing conjugation as a controllable bottleneck in resistance amplification, future interventions may shift the trajectory of AMR from expansion toward containment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.